Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
Clinical trial NCT02669719 · UNKNOWN
Trial details
- NCT number
- NCT02669719
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-01-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.